Genetics and biology of prostate cancer

G Wang, D Zhao, DJ Spring… - Genes & …, 2018 - genesdev.cshlp.org
Despite the high long-term survival in localized prostate cancer, metastatic prostate cancer
remains largely incurable even after intensive multimodal therapy. The lethality of advanced …

Tumor hypoxia: From basic knowledge to therapeutic implications

C Liao, X Liu, C Zhang, Q Zhang - Seminars in cancer biology, 2023 - Elsevier
Diminished oxygen availability, termed hypoxia, within solid tumors is one of the most
common characteristics of cancer. Hypoxia shapes the landscape of the tumor …

2-Oxoglutarate-dependent dioxygenases in cancer

JA Losman, P Koivunen, WG Kaelin Jr - Nature Reviews Cancer, 2020 - nature.com
Oxoglutarate-dependent dioxygenases (2OGDDs) are a superfamily of enzymes that play
diverse roles in many biological processes, including regulation of hypoxia-inducible factor …

Mechanisms that regulate the activities of TET proteins

K Joshi, S Liu, P Breslin SJ, J Zhang - Cellular and Molecular Life Sciences, 2022 - Springer
The ten–eleven translocation (TET) family of dioxygenases consists of three members,
TET1, TET2, and TET3. All three TET enzymes have Fe+ 2 and α-ketoglutarate (α-KG) …

ZNF397 deficiency triggers TET2-driven lineage plasticity and AR-targeted therapy resistance in prostate cancer

Y Xu, Y Yang, Z Wang, M Sjöström, Y Jiang… - Cancer …, 2024 - aacrjournals.org
Cancer cells exhibit phenotypical plasticity and epigenetic reprogramming that allows them
to evade lineage-dependent targeted treatments by adopting lineage plasticity. The …

Roles and regulations of TET enzymes in solid tumors

JK Bray, MM Dawlaty, A Verma, A Maitra - Trends in cancer, 2021 - cell.com
The mechanisms governing the methylome profile of tumor suppressors and oncogenes
have expanded with the discovery of oxidized states of 5-methylcytosine (5mC). Ten-eleven …

Recent advances in epigenetic biomarkers and epigenetic targeting in prostate cancer

A Kumaraswamy, KRW Leng, TC Westbrook, JA Yates… - European urology, 2021 - Elsevier
Context In addition to genetic alterations, epigenetic alterations play a crucial role during
prostate cancer progression. A better understanding of the epigenetic factors that promote …

The molecular biology of prostate cancer: current understanding and clinical implications

J Gandhi, A Afridi, S Vatsia, G Joshi, G Joshi… - Prostate cancer and …, 2018 - nature.com
Background With continuous progress over the past few decades in understanding
diagnosis, treatment, and genetics, much has been learned about the prostate cancer …

[HTML][HTML] Epigenetics in prostate cancer: clinical implications

V Conteduca, J Hess, Y Yamada, SY Ku… - … andrology and urology, 2021 - ncbi.nlm.nih.gov
Epigenetic alterations, including changes in DNA methylation, histone modifications and
nucleosome remodeling, result in abnormal gene expression patterns that contribute to …

Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers

L Sundaram, A Kumar, M Zatzman, A Salcedo… - Science, 2024 - science.org
To identify cancer-associated gene regulatory changes, we generated single-cell chromatin
accessibility landscapes across eight tumor types as part of The Cancer Genome Atlas …